Avidity Partners Management LP Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$4.8B
Holdings
92
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (92 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | LVLNSPDR SER TR | 3,300,000 | $296.6M | 6.18% | Call |
| 2 | AZNASTRAZENECA PLC | 3,700,000 | $245.5M | 5.11% | |
| 3 | ABBVABBVIE INC | 1,466,100 | $237.7M | 4.95% | |
| 4 | ARVNARVINAS INC | 2,915,300 | $196.2M | 4.09% | |
| 5 | ELVANTHEM INC | 399,400 | $196.2M | 4.09% | |
| 6 | MRKMERCK & CO INC | 2,370,000 | $194.5M | 4.05% | |
| 7 | AVTRAVANTOR INC | 5,668,300 | $191.7M | 3.99% | |
| 8 | BAXBAXTER INTL INC | 1,915,500 | $148.5M | 3.09% | |
| 9 | ZNTLZENTALIS PHARMACEUTICALS INC | 3,176,999 | $146.6M | 3.05% | |
| 10 | —BIOHAVEN PHARMACTL HLDG CO L | 1,231,000 | $146.0M | 3.04% | |
| 11 | VRTXVERTEX PHARMACEUTICALS | 545,600 | $142.4M | 2.96% | |
| 12 | UNHUNITEDHEALTH GROUP INC | 259,600 | $132.4M | 2.76% | |
| 13 | UTHUNITED THERAPEUTICS CORP DEL | 718,946 | $129.0M | 2.69% | |
| 14 | HZNPHORIZON THERAPEUTICS PUB L | 1,131,400 | $119.0M | 2.48% | |
| 15 | MRTXEURMIRATI THERAPEUTICS INC | 1,393,000 | $114.5M | 2.38% | |
| 16 | OPHTEURIVERIC BIO INC | 6,475,400 | $109.0M | 2.27% | |
| 17 | NBIXNEUROCRINE BIOSCIENCES INC | 1,160,000 | $108.8M | 2.26% | |
| 18 | IOVAIOVANCE BIOTHERAPEUTICS INC | 6,043,219 | $100.6M | 2.10% | |
| 19 | ISRGINTUITIVE SURGICAL INC | 325,000 | $98.0M | 2.04% | |
| 20 | CTLTEURCATALENT INC | 782,000 | $86.7M | 1.81% | |
| 21 | HUMHUMANA INC | 198,900 | $86.6M | 1.80% | |
| 22 | SNDXSYNDAX PHARMACEUTICALS INC | 4,823,400 | $83.8M | 1.75% | |
| 23 | BIIBBIOGEN INC | 365,000 | $76.9M | 1.60% | |
| 24 | RAREULTRAGENYX PHARMACEUTICAL IN | 869,000 | $63.1M | 1.31% | |
| 25 | JNJJOHNSON & JOHNSON | 354,000 | $62.7M | 1.31% | |
| 26 | TORCEURADICET BIO INC | 3,120,000 | $62.3M | 1.30% | |
| 27 | KZRKEZAR LIFE SCIENCES INC | 3,518,000 | $58.5M | 1.22% | |
| 28 | MCKMCKESSON CORP | 189,500 | $58.0M | 1.21% | |
| 29 | ARGXARGENX SE | 176,000 | $55.5M | 1.16% | |
| 30 | BSXBOSTON SCIENTIFIC CORP | 1,196,100 | $53.0M | 1.10% | |
| 31 | NTRANATERA INC | 1,300,000 | $52.9M | 1.10% | |
| 32 | EWEDWARDS LIFESCIENCES CORP | 440,000 | $51.8M | 1.08% | |
| 33 | ARWRARROWHEAD PHARMACEUTICALS IN | 955,000 | $43.9M | 0.91% | |
| 34 | IMCRIMMUNOCORE HLDGS PLC | 1,363,800 | $40.8M | 0.85% | |
| 35 | LEGNLEGEND BIOTECH CORP | 1,095,000 | $39.8M | 0.83% | |
| 36 | XBISPDR SER TR | 440,000 | $39.5M | 0.82% | |
| 37 | BHCBAUSCH HEALTH COS INC | 1,694,700 | $38.7M | 0.81% | |
| 38 | RNAAVIDITY BIOSCIENCES INC | 2,045,000 | $37.8M | 0.79% | |
| 39 | IM8NINSMED INC | 1,354,539 | $31.8M | 0.66% | |
| 40 | ATECALPHATEC HLDGS INC | 2,735,600 | $31.5M | 0.66% | |
| 41 | IDYAIDEAYA BIOSCIENCES INC | 2,690,000 | $30.1M | 0.63% | |
| 42 | CCXIEURCHEMOCENTRYX INC | 1,175,000 | $29.5M | 0.61% | |
| 43 | AXSMAXSOME THERAPEUTICS INC | 711,000 | $29.4M | 0.61% | |
| 44 | RCUSARCUS BIOSCIENCES INC | 912,000 | $28.8M | 0.60% | |
| 45 | NTLAINTELLIA THERAPEUTICS INC | 390,075 | $28.3M | 0.59% | |
| 46 | PHATPHATHOM PHARMACEUTICALS INC | 1,946,000 | $26.5M | 0.55% | |
| 47 | CRBUCARIBOU BIOSCIENCES INC | 2,819,067 | $25.9M | 0.54% | |
| 48 | NUVBNUVATION BIO INC | 4,855,006 | $25.5M | 0.53% | |
| 49 | BLUBELLUS HEALTH INC NEW | 3,685,000 | $25.4M | 0.53% | |
| 50 | SPNEUSDSEASPINE HLDGS CORP | 2,010,000 | $24.4M | 0.51% | |
| 51 | PENPENUMBRA INC | 104,000 | $23.1M | 0.48% | |
| 52 | SIBNSI-BONE INC | 1,000,000 | $22.6M | 0.47% | |
| 53 | VIRVIR BIOTECHNOLOGY INC | 780,000 | $20.1M | 0.42% | |
| 54 | VRDNVIRIDIAN THERAPEUTICS INC | 1,040,000 | $19.2M | 0.40% | |
| 55 | 2L9BLUEPRINT MEDICINES CORP | 291,184 | $18.6M | 0.39% | |
| 56 | ALTALTIMMUNE INC | 2,865,000 | $17.4M | 0.36% | |
| 57 | EPIEURESSA PHARMA INC | 2,460,000 | $15.2M | 0.32% | |
| 58 | SGENUSDSEAGEN INC | 100,000 | $14.4M | 0.30% | |
| 59 | GLPGGALAPAGOS NV | 215,000 | $13.3M | 0.28% | |
| 60 | IPSCCENTURY THERAPEUTICS INC | 865,000 | $10.9M | 0.23% | |
| 61 | NVLSEURALPINE IMMUNE SCIENCES INC | 1,207,000 | $10.8M | 0.23% | |
| 62 | APLSAPELLIS PHARMACEUTICALS INC | 210,000 | $10.7M | 0.22% | |
| 63 | ANTXAN2 THERAPEUTICS INC | 688,330 | $10.4M | 0.22% | |
| 64 | ERASERASCA INC | 995,000 | $8.6M | 0.18% | |
| 65 | SSENTINELONE INC | 204,500 | $7.9M | 0.16% | |
| 66 | CYTCYTEIR THERAPEUTICS INC | 1,850,000 | $7.0M | 0.15% | |
| 67 | —PHASEBIO PHARMACEUTICALS INC | 4,405,000 | $5.8M | 0.12% | |
| 68 | —CAREMAX INC | 755,329 | $5.6M | 0.12% | |
| 69 | TNGXTANGO THERAPEUTICS INC | 721,000 | $5.5M | 0.11% | |
| 70 | HYPRHYPERFINE INC | 1,503,754 | $5.3M | 0.11% | |
| 71 | —MEDICUS SCIENCES ACQUISITION | 520,000 | $5.1M | 0.11% | |
| 72 | —BCLS ACQUISITION CORP | 500,000 | $4.9M | 0.10% | |
| 73 | —DYNAMICS SPECIAL PURPOSE COR | 500,000 | $4.9M | 0.10% | |
| 74 | —ARYA SCIENCES ACQU CORP IV | 500,000 | $4.9M | 0.10% | |
| 75 | —PANACEA ACQUISITION CORP II | 500,000 | $4.9M | 0.10% | |
| 76 | MLTXHELIX ACQUISITION CORP | 400,000 | $4.4M | 0.09% | |
| 77 | —FIELD TRIP HEALTH LTD | 2,976,000 | $4.0M | 0.08% | |
| 78 | —HEALTH SCIENCES ACQ CORP 2 | 400,000 | $4.0M | 0.08% | |
| 79 | GRPHGRAPHITE BIO INC | 710,000 | $3.6M | 0.08% | |
| 80 | —ONCOSEC MED INC | 2,945,000 | $3.4M | 0.07% | |
| 81 | OTICEUROTONOMY INC | 1,349,905 | $3.2M | 0.07% | |
| 82 | SMFRUSDSEMA4 HOLDINGS CORP | 950,000 | $2.9M | 0.06% | |
| 83 | CMPXCOMPASS THERAPEUTICS INC | 2,000,000 | $2.7M | 0.06% | |
| 84 | 2JQGRITSTONE BIO INC | 560,000 | $2.3M | 0.05% | |
| 85 | —SCIENCE 37 HOLDINGS INC | 430,000 | $2.3M | 0.05% | |
| 86 | SCYXSCYNEXIS INC | 544,043 | $2.1M | 0.04% | |
| 87 | —SOCIAL CAP SUVRETTA HLD CRPI | 200,000 | $2.0M | 0.04% | |
| 88 | —SOCIAL CAP SUVRETTA HLDS CRP | 200,000 | $2.0M | 0.04% | |
| 89 | —SOCIAL CAP SUVRETTA HLDS CRP | 200,000 | $1.9M | 0.04% | |
| 90 | —SOCIAL CAP SUVRETTA HLDS CP | 200,000 | $1.9M | 0.04% | |
| 91 | NUVB/WSNUVATION BIO INC | 99,999 | $76K | 0.00% | |
| 92 | —MEDICUS SCIENCES ACQUISITION | 57,770 | $25K | 0.00% |